ResMed Inc. (ASX:RMD) has announced its results for Q4, showing an 8 percent increase in revenue on the prior corresponding period.

 

The results exclude the contribution from the company’s recently completed $800 million Brightree acquisition.

 

Revenues across both the American and European regions were up, however gross margins for the quarter dropped compared to the same period last year.

 

A quarterly dividend of $0.33 per share has been declared, a 10 percent increase from the previous dividend.

 

ResMed Inc. reported a net profit of $233.9 million at 31 December 2015.